For Manuscript Submission, Check or Review Login please go to Submission Websites List.
For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.
Acupuncture in Seasonal Allergic Rhinitis (ACUSAR) – Design and Protocol of a Randomised Controlled Multi-Centre TrialBrinkhaus B.a · Witt C.M.a · Ortiz M.a · Roll S.a · Reinhold T.a · Linde K.b · Pfab F.c, d · Niggemann B.e · Hummelsberger J.f · Irnich D.g · Wegscheider K.h · Willich S.N.a
a Institute for Social Medicine, Epidemiology, and Health Economics, Charité – University Medical Center, Berlin, b Institute of General Practice, Klinikum rechts der Isar, Technische Universität München, Munich, c Department of Dermatology and Allergy, Technische Universität München, Munich, d Division of Environmental Dermatology and Allergy, Helmholtz Zentrum München/TUM, ZAUM-Center for Allergy and Environment, Munich, e Pediatric Allergology and Pneumology, German Red Cross Hospital Westend, Berlin, f International Society for Chinese Medicine (Societas Medicinae Sinensis, SMS), Munich, g Department of Anaesthesiology, Ludwig-Maximilians-University, Munich, h Department of Medical Biometry and Epidemiology, University Medical Center Eppendorf, Hamburg, Germany
Background: We report on the study design and protocol of a randomised controlled trial (Acupuncture in Seasonal Allergic Rhinitis, ACUSAR) that investigates the efficacy of acupuncture in the treatment of seasonal allergic rhinitis (SAR). Objective: To investigate whether acupuncture is non-inferior or superior to (a) penetrating sham acupuncture and (b) rescue medication in the treatment of SAR. Design: 3-armed, randomised controlled multi-centre trial with a total follow-up time of 16 weeks in the 1st year and 8 weeks in the 2nd year. Setting: 41 physicians in 37 out-patient units in Germany specialised in acupuncture treatment. Patients: 400 seasonal allergic rhinitis patients with clinical symptoms and test-positive (skin-prick test and/or specific IgE) to both birch and grass pollen. Interventions: Patients will be randomised in a 2:1:1 ratio to one of three groups: (a) semi-standardised acupuncture plus rescue medication (cetirizine); (b) penetrating sham acupuncture at non-acupuncture points plus rescue medication; or (c) rescue medication alone for 8 weeks (standard treatment group). Acupuncture and sham acupuncture will consist of 12 treatments per patient over 8 weeks. Main Outcome Measures: Average means of the Rhinitis Quality of Life Questionnaire (RQLQ) overall score and the Rescue Medication Score (RMS) between weeks 6 and 8 in the first year, adjusted for baseline values. Outlook: The results of this trial available in 2011 will have a major impact on the decision of whether acupuncture should be considered as a therapeutic option in the treatment of SAR.
© 2010 S. Karger AG, Basel